PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical Laboratory, Xixi Hospital of Hangzhou, Hangzhou, China.\', \'Medical Laboratory, Xixi Hospital of Hangzhou, Hangzhou, China; Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.\', \'Department of Radiology, Xixi Hospital of Hangzhou, Hangzhou, China.\', \'Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: jameszhang2000@zju.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(20)30132-610.1016/j.ijid.2020.03.013
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 32173576
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all